Salvarx Share Discussion Threads

[the stigologist] 22/10/2018 09:09

Should be a double whammy effect coming Portage value will go up and have a knock on effect on the SALV price Should go exponential soon No wonder they were giving the October 20th Presentation such a pre-show fanfare and they delivered !

[the stigologist] 22/10/2018 07:32

htTps://twitter.com/Rollinopi/status/1054273687699054592

[jonesyboy 27] 21/10/2018 17:47

The only way to remain holding intensity is to hold portage. Interesting to note that portage gave a dividend of $210 million in January when they sold shares in Biohaven. They will do the same with Intensity. Can see a fairly quick sale.

[bscuit] 21/10/2018 17:35

Running for free for me. Will offset other losses if I sell, but on enquiry Canadian disposal costs aren’t horrific, so I will let it run meantime especially as indications are that the P shares will be a capital receipt as Vod/Verizon were.

[fig1] 21/10/2018 17:20

Shame, but a bird in the hand.... Fig.

[fig1] 21/10/2018 17:18

Similar here Dex. I have a few more @34p. I saw a corporate vid on a J Mellon tweet. Looked interesting to me. I liked the business model. Won't make me a mill but hope for the best. Good luck to you. Fig.

[dexdringle] 21/10/2018 16:39

My problem is going to be that I won't want to be holding Portage shares (not even sure i can [Charles Stanley]) so will be looking to sell before the swap...

[jonesyboy 27] 21/10/2018 16:34

This is way undervalued even pre stunning results. Price agreed is worth $1.60 in portage shares with a healthy percentage of the deal shares remaining in the shell. That wecretwkn our shares in. No brainer chaps.

[jonesyboy 27] 21/10/2018 15:55

Plenty of screen printe on twitter search #SALV. We will have a very interesting week, expecting portage SH document release by Canadian stock Exchange early this week. Vote then deal very quickly. Don’t forget we get 18 portage shares (value US 8.9 cents each) for every Salv share. Plus get to keep shell shares which are worth ~20p each.

[dexdringle] 21/10/2018 15:44

fig1. I have a small holding. Just 6,000 shares. A speculative punt at around 34p a share a while ago. Tip from Moneyweek I think but i can't be sure. Could do with a significant winner as am taking a major bath on some other holdings just now.... Jonesboy. Source ? Your estimate of effect it may have on the share price ?

[jonesyboy 27] 21/10/2018 14:32

The news was stunning. We have proven immuno-response. This is key. Necrosis (death) of the tumour. 90% of the drug remains in the tumour (think about that and the damage current methods do to surrounding tissue). Decrease in cancer related symptoms. All good. This will be taken massive by a major or a partner. In short Tumours die and proven engagement of the immune system. An amazing weekend for any lucky shareholders of SALV. Well done all for holding.

[fig1] 21/10/2018 14:18

Why are you interested Dex? Do you currently have a holding in SalvaRx or FFWD?

[dexdringle] 21/10/2018 11:25

I came on here today expecting a load of posts re some news yesterday, as expected in previous posts on here, that Intensity had made a world changing breakthrough and that Salvarx's 9% would be worth a fortune. Instead just tumbleweed.... Presumably no such news / progress after all ?

[the stigologist] 19/10/2018 15:09

Well I don't want to be short this over the weekend

[the stigologist] 19/10/2018 00:29

Hmm just one trading day left before the BIG presentation

[dexdringle] 18/10/2018 12:32

…..the Portage update on 9th October merely confirmed that Canadian Stock Exchange is still 'checking the paperwork': https://www.bloomberg.com/press-releases/2018-10-09/portage-provides-update-on-proposed-acquisition-of-salvarx Good god. How long do these things take ?

[the stigologist] 17/10/2018 11:10

Fast Forward and Intensity really building up October 20th presentation on Twitter Could/should be interesting weeks ahead

[dexdringle] 02/10/2018 07:09

Stig - are you old enough to remember Chesney Hawkes ?

[the stigologist] 01/10/2018 23:54

Portage has a history of creating value for its shareholders - one of its portfolio companies, Biohaven Pharmaceutical Holding Company Ltd ("Biohaven") (NYSE:BHVN), was the second largest biotech IPO on NASDAQ in 2017. Portage subsequently announced a distribution in specie of its stock in Biohaven to its shareholders. Their initial US$7 million investment was worth in excess of US$100 million at the time of the IPO in 2017, and has almost doubled since then. Biohaven is now worth approximately US$1.3 billion. Portage has provided seed capital to four other biotech companies and will seek to evaluate new opportunities. I am excited at the potential of working with the Portage team to progress our combined portfolio.

[fig1] 30/9/2018 18:34

This could just be one of the most profitable trades Jim Mellon has been involved in.

[bscuit] 25/9/2018 05:28

Their website contact form doesn’t work so have had to ask broker to try to get it.